Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137678049> ?p ?o ?g. }
- W2137678049 endingPage "380" @default.
- W2137678049 startingPage "373" @default.
- W2137678049 abstract "Two cholinesterase inhibitors (ChEIs), rivastigmine and galantamine, are used to treat Alzheimer disease in the Netherlands. Several adverse cardiac events have been reported for these medications. We aimed to assess if the use of ChEIs increased the risk of cardiac events in the Netherlands. A cohort crossover study of the PHARMO Record Linking System database included patients who initiated ChEIs at age 50 years or older, had at least 1 dispensing of a ChEI drug between 1998 and 2008, a 1-year history in PHARMO, and 1 subsequent dispensing of any medication. Two outcomes were assessed: a first hospitalization for syncope or atrioventricular block. Poisson and Cox regression were used to calculate incidence densities and hazard ratios for cardiac events during periods with ChEI use, compared with periods without ChEI use. During the complete observation period of 8.9 years (interquartile range 6.7 to 10.2) there were 132 first hospitalizations for atrioventricular block and 17 first hospitalizations for syncope among 3358 patients. The adjusted incidence densities were significantly increased during ChEI exposure for syncope and atrioventricular block, when compared with the background incidence densities in the roughly 5 years before the last year before ChEI initiation. However, when exposed periods were compared with the unexposed periods 1 year before ChEI initiation and times after exposure, the adjusted hazard ratios remained increased for syncope and atrioventricular block, but increases were not significant anymore. Exposure to ChEIs might increase the risk of adverse cardiac events, but small numbers of cases limit conclusions about the risk in this population and research on larger study samples is needed." @default.
- W2137678049 created "2016-06-24" @default.
- W2137678049 creator A5010267384 @default.
- W2137678049 creator A5024588131 @default.
- W2137678049 creator A5031896279 @default.
- W2137678049 creator A5042146189 @default.
- W2137678049 creator A5042862186 @default.
- W2137678049 creator A5084013498 @default.
- W2137678049 date "2012-12-01" @default.
- W2137678049 modified "2023-09-27" @default.
- W2137678049 title "Use of Rivastigmine or Galantamine and Risk of Adverse Cardiac Events: A Database Study from the Netherlands" @default.
- W2137678049 cites W1965761548 @default.
- W2137678049 cites W1974762860 @default.
- W2137678049 cites W1982738872 @default.
- W2137678049 cites W1984272022 @default.
- W2137678049 cites W2012242765 @default.
- W2137678049 cites W2014886338 @default.
- W2137678049 cites W2036222770 @default.
- W2137678049 cites W2042353763 @default.
- W2137678049 cites W2060446879 @default.
- W2137678049 cites W2073245686 @default.
- W2137678049 cites W2077821812 @default.
- W2137678049 cites W2079443593 @default.
- W2137678049 cites W2086567283 @default.
- W2137678049 cites W2136318393 @default.
- W2137678049 cites W2136527705 @default.
- W2137678049 cites W2144418705 @default.
- W2137678049 cites W2147350792 @default.
- W2137678049 cites W2150546617 @default.
- W2137678049 cites W960146918 @default.
- W2137678049 doi "https://doi.org/10.1016/j.amjopharm.2012.11.002" @default.
- W2137678049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23217530" @default.
- W2137678049 hasPublicationYear "2012" @default.
- W2137678049 type Work @default.
- W2137678049 sameAs 2137678049 @default.
- W2137678049 citedByCount "14" @default.
- W2137678049 countsByYear W21376780492013 @default.
- W2137678049 countsByYear W21376780492014 @default.
- W2137678049 countsByYear W21376780492015 @default.
- W2137678049 countsByYear W21376780492018 @default.
- W2137678049 countsByYear W21376780492019 @default.
- W2137678049 countsByYear W21376780492023 @default.
- W2137678049 crossrefType "journal-article" @default.
- W2137678049 hasAuthorship W2137678049A5010267384 @default.
- W2137678049 hasAuthorship W2137678049A5024588131 @default.
- W2137678049 hasAuthorship W2137678049A5031896279 @default.
- W2137678049 hasAuthorship W2137678049A5042146189 @default.
- W2137678049 hasAuthorship W2137678049A5042862186 @default.
- W2137678049 hasAuthorship W2137678049A5084013498 @default.
- W2137678049 hasConcept C120665830 @default.
- W2137678049 hasConcept C121332964 @default.
- W2137678049 hasConcept C126322002 @default.
- W2137678049 hasConcept C197934379 @default.
- W2137678049 hasConcept C201903717 @default.
- W2137678049 hasConcept C207103383 @default.
- W2137678049 hasConcept C2776332859 @default.
- W2137678049 hasConcept C2778375690 @default.
- W2137678049 hasConcept C2778715236 @default.
- W2137678049 hasConcept C2779056891 @default.
- W2137678049 hasConcept C2779134260 @default.
- W2137678049 hasConcept C2779483572 @default.
- W2137678049 hasConcept C2780904820 @default.
- W2137678049 hasConcept C44249647 @default.
- W2137678049 hasConcept C50382708 @default.
- W2137678049 hasConcept C61511704 @default.
- W2137678049 hasConcept C71924100 @default.
- W2137678049 hasConcept C72563966 @default.
- W2137678049 hasConceptScore W2137678049C120665830 @default.
- W2137678049 hasConceptScore W2137678049C121332964 @default.
- W2137678049 hasConceptScore W2137678049C126322002 @default.
- W2137678049 hasConceptScore W2137678049C197934379 @default.
- W2137678049 hasConceptScore W2137678049C201903717 @default.
- W2137678049 hasConceptScore W2137678049C207103383 @default.
- W2137678049 hasConceptScore W2137678049C2776332859 @default.
- W2137678049 hasConceptScore W2137678049C2778375690 @default.
- W2137678049 hasConceptScore W2137678049C2778715236 @default.
- W2137678049 hasConceptScore W2137678049C2779056891 @default.
- W2137678049 hasConceptScore W2137678049C2779134260 @default.
- W2137678049 hasConceptScore W2137678049C2779483572 @default.
- W2137678049 hasConceptScore W2137678049C2780904820 @default.
- W2137678049 hasConceptScore W2137678049C44249647 @default.
- W2137678049 hasConceptScore W2137678049C50382708 @default.
- W2137678049 hasConceptScore W2137678049C61511704 @default.
- W2137678049 hasConceptScore W2137678049C71924100 @default.
- W2137678049 hasConceptScore W2137678049C72563966 @default.
- W2137678049 hasIssue "6" @default.
- W2137678049 hasLocation W21376780491 @default.
- W2137678049 hasLocation W21376780492 @default.
- W2137678049 hasOpenAccess W2137678049 @default.
- W2137678049 hasPrimaryLocation W21376780491 @default.
- W2137678049 hasRelatedWork W2026094606 @default.
- W2137678049 hasRelatedWork W2071306276 @default.
- W2137678049 hasRelatedWork W2162970695 @default.
- W2137678049 hasRelatedWork W2373211733 @default.
- W2137678049 hasRelatedWork W2597513447 @default.
- W2137678049 hasRelatedWork W2611840721 @default.
- W2137678049 hasRelatedWork W2807947270 @default.
- W2137678049 hasRelatedWork W3110151069 @default.